1Delvanx M, Frexinos J. A European approach to irritable bowel syndrome management. Can J GatroenteroI, 1999,13(Suppl A) :85A.
2Dumitrascu DL, Ungureanu O, Verzea D , et al, The effect of metoclopramide on antral emptying of a semisolid meal in patientswith functional dyspepsia. A randomized placebo controlled snographic study. Rom J Intern Med , 1998, 36 ( 1 - 2) : 97 - 104.
3Durazo FA, Valenzuela JE. Effect of single and repeated doses of metoclopramide on the mechanisms of gastroesophageal reflux. Am J Gastroenteml , 1993,88 (10) : 1657 - 1662.
4Orr WC, Finn A, Wilson T, et al. Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide. Am J Gastroenterol , 1990,85(6) :697 - 700.
5Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M , et al. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol, 2001, 96 (3):689-696.
6Finney JS, Kinnersley N, Hughes M, et al. Meta - analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol, 1998,26(4):312-320.
7Tsubouchi T, Saito T, Mizutani F, et al. Stimulatory Action of Itopride Hydrochloride on Colonic Motor Activity In Vitro and In Vivo. J Pharmaeol Exp Ther , 2003,30 [epub ahead of print].
8Ruth M, Hamelin B, Rohss K, et al. The effect of rnosapride, a novel prokinetic, on acid reflux variablm in patients with gastm-oesophageal réflux disease. Aliment Pharmaeot Ther, 1998, 12(1):35-40.
9Olden K, DeGarmo RG, Jhingran P, et al. Patient satisfaction with alosetron for the treatment of women with diarrhea- predominant irritable bowel syndrome. Am J Gastroenterol 2002, 97(12) : 3139 - 3146.
10Battaglia G, Marselli - Labate AM, Gamarri E, et al. Otilonium abromide in the irritable bowel syndrome: a double- blind, placebo controlled, 15 week study in a large number of patients. Ailment Pharmacol Ther,1998, 12:1003 - 1010.
